Literature DB >> 25895555

Prognostic value of serial brain natriuretic Peptide measurements in patients with acute myocardial infarction.

Antonio E P Pesaro1, Marcelo Katz, Adriano Caixeta, Márcia R Makdisse, Alessandra G Correia, Carolina Pereira, Marcelo Franken, Anderson N Fava, Carlos V Serrano.   

Abstract

OBJECTIVES: Elevated B-type natriuretic peptide (BNP) levels following acute myocardial infarction (AMI) are associated with adverse outcomes. The role of serial BNP monitoring after AMI has been poorly investigated. We aimed to evaluate the prognostic value of in-hospital serial BNP measurements in AMI patients.
METHODS: Patients with AMI (n=1,924) were retrospectively evaluated. We selected patients with at least 2 in-hospital BNP measurements. The association between in-hospital mortality and BNP measurements (earliest, highest follow-up and the variation between measurements) were tested in multivariate models.
RESULTS: Serial BNP levels were determined in 176 patients. Compared to the rest of the population, these patients were older and had higher mortality rates. In the adjusted models, only the highest follow-up BNP remained associated with in-hospital death (odds ratio 1.06; 95% confidence interval, CI, 1.01-1.15; p=0.014). Receiver-operating characteristic curve analysis demonstrated that the highest follow-up BNP was the best predictor of in-hospital death (area under the curve=0.75; 95% CI 0.64-0.86).
CONCLUSIONS: Serial BNP monitoring was performed in a high-risk subgroup of AMI patients. The highest follow-up BNP was a better predictor of short-term death than the baseline and in-hospital variation values. In AMI patients, a later in-hospital BNP assessment may be more useful than an early measurement.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25895555     DOI: 10.1159/000375398

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  3 in total

1.  [Dynamic changes of brain natriuretic peptide concentration and its diagnostic value for heart failure in early phase of acute myocardial infarction].

Authors:  Huidi Li; Dingcheng Xiang; Jinxia Zhang; Tianbing Duan; Feng Long; Aimin Li
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-01-30

2.  Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores.

Authors:  Dirk Aam Schellings; Ahmet Adiyaman; Jan-Henk E Dambrink; At Marcel Gosselink; Elvin Kedhi; Vincent Roolvink; Jan Paul Ottervanger; Arnoud Wj Van't Hof
Journal:  Vasc Health Risk Manag       Date:  2016-11-21

3.  Effects of DPP4 Inhibitor in Platelet Reactivity and Other Cardiac Risk Markers in Patients with Type 2 Diabetes and Acute Myocardial Infarction.

Authors:  Paulo R Rizzo Genestreti; Remo H M Furtado; Rocio Salsoso; Talia F Dalçóquio; Andre Franci; Fernando R Menezes; Cesar Caporrino; Aline G Ferrari; Carlos A K Nakashima; Marco A Scanavini Filho; Felipe G Lima; Roberto R C V Giraldez; Luciano M Baracioli; Jose C Nicolau
Journal:  J Clin Med       Date:  2022-09-29       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.